Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
3
×
life sciences
national blog main
biotech
boston blog main
boston top stories
clinical trials
drugs
national
national top stories
new york blog main
new york top stories
pfizer
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
ucb
89bio
abaloparatide
abbvie
adrian krainer
akcea therapeutics
alexion pharmaceuticals
alnylam pharmaceuticals
alzheimer europe conference
alzheimer's disease
amgen
astrazeneca
bain capital
biogen
biotech ipos
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
cerevel therapeutics
convergence pharmaceuticals
What
drug
europe
3
×
medicine
alnylam
alzheimer’s
amgen
amgen’s
annual
approval
approves
assessed
attention
bio
biotech
carries
cells
communities
conference
developed
ema
employ
esmo
european
fda
follows
gene
germany
harmful
heart
hits
hosted
interference
investment
make
marketing
method
munich
mute
nod
osteoporosis
Language
unset
Current search:
europe
×
fda
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
